Analysis Metabolite Name Measured Value Units Exercise Group Sex Type
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+23128Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+27222Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+37002Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+39531Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+39814Peak area normalizedNo Normal Pressures Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+42890Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+49225Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+50872Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+51140Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+54153Peak area normalizedNo PAH Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+54323Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+54529Peak area normalizedYes Normal Pressures Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+54922Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+55824Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+61398Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+62143Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+63914Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+63989Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+64039Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+65871Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+68030Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+69356Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+69566Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+70605Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+71953Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+72182Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+72468Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+72629Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+72765Peak area normalizedNo Healthy Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+73128Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+73344Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+73348Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+73405Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+73989Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+74185Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+74589Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+76858Peak area normalizedNo LowRisk Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+77291Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+77886Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+78083Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+78155Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+79715Peak area normalizedYes PAH Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+79941Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+80055Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+80683Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+80882Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+81050Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+82801Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+84140Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+84682Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+85803Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+87122Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+87292Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+87848Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+89023Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+90906Peak area normalizedYes LowRisk Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+90938Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+92243Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+93959Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+94596Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+95221Peak area normalizedNo Healthy Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+96010Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+96888Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+97442Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+97524Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+97642Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+98410Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+99488Peak area normalizedYes Healthy Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+99507Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+99710Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+100322Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+101232Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+102652Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+102671Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+102754Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+103115Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+103369Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+103535Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+103726Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+104585Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+105170Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+105429Peak area normalizedNo Healthy Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+106355Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+106565Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+111274Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+111277Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+111539Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+111539Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+112678Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+113750Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+114720Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+115098Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+115289Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+118158Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+118709Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+119100Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+119692Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+120220Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+120345Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+120751Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+121538Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+124123Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+124207Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+124802Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+125564Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+125977Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+127574Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+127701Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+127780Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+128036Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+129159Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+129268Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+129407Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+130644Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+131170Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+131832Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+132357Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+134195Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+134667Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+135462Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+136832Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+137327Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+139252Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+142766Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+144320Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+145674Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+145860Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+146026Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+150661Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+151245Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+151483Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+152174Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+152359Peak area normalizedNo PAH Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+153312Peak area normalizedYes PAH Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+154252Peak area normalizedYes Healthy Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+154599Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+155140Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+155166Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+155317Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+156136Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+156571Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+157440Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+157835Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+159027Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+159797Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+161768Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+162676Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+162722Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+164248Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+165313Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+165637Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+168697Peak area normalizedNo PAH Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+170629Peak area normalizedYes Healthy Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+173278Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+176634Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+178352Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+182761Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+184682Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+189005Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+190142Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+194824Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+198582Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+199531Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+207243Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+213110Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+217091Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+218317Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+224072Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+226241Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+227031Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+230077Peak area normalizedYes LowRisk Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+232105Peak area normalizedNo LowRisk Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+260109Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+398211Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+1579597Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedNo Healthy Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedYes Healthy Male Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedYes PAH Male Cath

Return to search page
  logo